1. Alice N. Schwartz, Bio-Rad co-founder, passed away at age 99. 2. She co-founded Bio-Rad in 1952, fostering growth in clinical diagnostics. 3. Schwartz developed Bio-Rad's first thyroid function test kit in the 1960s. 4. She shaped Bio-Rad's vision and served as a board member until 2022. 5. Her legacy continues to inspire Bio-Rad and the scientific community.
While her passing marks a significant loss, it does not immediately impact stock valuation, similar to past leadership transitions in major companies where stock behavior remained stable post-event.
The article holds moderate importance as it affects company leadership and future strategic initiatives, possibly impacting investor confidence in the long run.
The long-term impact may involve shifts in company direction or strategy following her legacy, paralleling how other firms adjust after pivotal founder losses, adjusting investor sentiments gradually.
Bio-Rad Laboratories, Inc. (NYSE: BIO), a global leader in life science research and clinical diagnostics products, today announced that Alice N. Schwartz, Bio-Rad's co-founder and Director Emeritus, passed away on September 25, 2025, at the age of 99.
Mrs. Schwartz co-founded Bio-Rad in 1952 in Berkeley, California, together with her husband David Schwartz, shortly after graduating with a biochemistry degree from the University of California, Berkeley.
The company began by developing specialty chemicals for life science research and later expanded into clinical diagnostics. Alice Schwartz was instrumental in the development of Bio-Rad's first test kit for thyroid function in the 1960's, which was based on separation techniques and materials developed for life science research. This innovation marked Bio-Rad's entry into the field of clinical diagnostics, and set the stage for the company's future growth and success.
Mrs. Schwartz played a key role in Bio-Rad's achievements and remained an active Board member until 2022. Her leadership and passion for scientific discovery created a legacy that continues to inspire the company and the broader scientific community.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,500 employees, and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250929203438/en/
Investor Contact:
Edward Chung, Investor Relations
510-741-6104
ir@bio-rad.com
Media Contact:
Anna Gralinska, Corporate Communications
510-741-6643
cc@bio-rad.com